NEBGH Members only, Webinar

NEBGH’s Medical Director Weekly Monday COVID-19 Update: w/ Harvard Epidemiologist Dr. Michael Mina

Hear the latest COVID update from NEBGH Medical Director Dr. Mark Cunningham-Hill!

This special edition features a discussion with Dr. Michael Mina – a vocal proponent of rapid testing as a way out of the COVID pandemic.   

Featured Speaker

Michael Mina, MD, PhD

Assistant Professor Center for Communicable Disease Dynamics, Department of Epidemiology
Harvard T.H. Chan School of Public Health

Dr. Michael Mina, MD, PhD is an Assistant Professor of Epidemiology at Harvard T. H. Chan School of Public Health and a core member of the Center for Communicable Disease Dynamics (CCDD). He is additionally an Assistant Professor in Immunology and Infectious Diseases at HSPH and Associate Medical Director in Clinical Microbiology (molecular diagnostics) in the Department of Pathology at Brigham and Women’s Hospital, Harvard Medical School

He earned his MD and PhD degrees from Emory University, with doctoral work split between CDC, St. Jude Children’s Research Hospital, the Respiratory and Meningeal Pathogens Research Unit in Johannesburg, South Africa and the Emory Vaccine Center. He completed his post-doctoral work at Princeton University in Ecology and Evolutionary Biology (of infectious disease dynamics) with Prof. Bryan Grenfell and at Harvard Medical School in the Department of Genetics with Prof. Stephen Elledge. He completed his residency training in clinical pathology at Brigham and Women’s Hospital / Harvard Medical School.

Michael’s research combines mathematical and epidemiological models with high-throughput phage-display based serological laboratory investigations, including development of new technologies and statistical pipelines to better understand the population and immunological consequences and patterns underlying infectious diseases. Much of the work towards new technology development is performed in close collaboration with Steve Elledge at HMS. Major themes of his lab include (i) development of new approaches (laboratory and statistical methods) to enable extremely high-throughput serological surveillance of infectious pathogens; (ii) use of high-complexity antibody profiling and epidemiological data to understand the pathogenesis of vaccine preventable diseases, with a specific focus on measles infections and vaccines; (iii) elucidating broad unintended / heterologous effects of vaccines to alter transmission patterns of unrelated infectious pathogens – using serology and dynamical models; and (iv) understanding the life-history of infectious pathogens across ages, genders, geographies and times. In addition to his interests in infectious diseases, his research also explores more fundamental questions of immunity and immune repertoires: how they form, how they persist, how they are passed on and how they become perturbed during natural life-events.

You can read a recent Q&A with Dr. Mina here.

with

Dr. Mark Cunningham-Hill

Medical Director
NEBGH

Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of  social, cultural and racial determinants of health.

Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.

Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.